HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) Director Jon Kessler sold 134,183 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the sale, the director now directly owns 253,510 shares in the company, valued at $28,413,400.80. This represents a 34.61% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Jon Kessler also recently made the following trade(s):
- On Friday, June 6th, Jon Kessler sold 97,767 shares of HealthEquity stock. The shares were sold at an average price of $112.05, for a total transaction of $10,954,792.35.
HealthEquity Stock Performance
Shares of HQY traded up $0.77 during mid-day trading on Friday, reaching $104.76. 854,492 shares of the company's stock were exchanged, compared to its average volume of 835,087. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market capitalization of $9.06 billion, a PE ratio of 96.11, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. The business's fifty day simple moving average is $93.96 and its 200-day simple moving average is $97.89. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $116.65.
HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm posted $0.80 earnings per share. On average, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.
Hedge Funds Weigh In On HealthEquity
Hedge funds and other institutional investors have recently bought and sold shares of the company. Entropy Technologies LP acquired a new stake in HealthEquity in the fourth quarter valued at $224,000. Peterson Wealth Services lifted its holdings in HealthEquity by 5.1% in the fourth quarter. Peterson Wealth Services now owns 10,507 shares of the company's stock valued at $1,008,000 after acquiring an additional 509 shares during the period. Louisiana State Employees Retirement System lifted its holdings in HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after acquiring an additional 100 shares during the period. Legato Capital Management LLC acquired a new stake in HealthEquity in the fourth quarter valued at $778,000. Finally, Rhumbline Advisers lifted its holdings in HealthEquity by 0.4% in the fourth quarter. Rhumbline Advisers now owns 267,288 shares of the company's stock valued at $25,646,000 after acquiring an additional 1,011 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the stock. The Goldman Sachs Group raised their target price on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, June 4th. Royal Bank of Canada raised their target price on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft raised their target price on shares of HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. Bank of America raised their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Finally, JMP Securities increased their price target on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research note on Wednesday, June 4th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $118.09.
Check Out Our Latest Stock Analysis on HQY
About HealthEquity
(
Get Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
